The global crisis of antimicrobial resistance (AMR) and the ever-decreasing supply of effective antibiotics are reaching a critical point. Two years on from Lord O’Neil’s landmark AMR report, what is required from industry, government and the public to ensure that this potential health catastrophe is addressed correctly? Dr Peter Jackson of the AMR Centre, which is spearheading the UK’s response to the need to develop new drugs for AMR, discusses what is needed to support the fight against one of the greatest threats to public health today.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/10/Situation-critical_antimicrobial-resistance.pdf” width=”100%” height=”900px” style=”border:0;”]